Associations of single nucleotide polymorphisms in mir-146a, mir-196a, mir-149 and mir-499 with colorectal cancer susceptibility

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 1047-1055

  Du, Wei ^a   Ma, Xue Lei ^a   Zhao, Chong ^b   Liu, Tao ^c   Du, Yu Liang ^d   Kong, Wei Qi ^a   Wei, Ben Ling ^e   Yu, Jia Yun ^a   Li, Yan Yan ^a   Huang, Jing Wen ^a   Li, Zi Kang ^c   Liu, Lei ^a  

^a SICHUAN UNIVERSITY   (China)

^b The 7th Hospital of Chengdu City   (China)

^c Ya'an People Hospital   (China)

^d Xinjin People Hospital   (China)

^e XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Meta analysis; MicroRNA; Polymorphism

Indexed keywords

MICRORNA; MIRN146 MICRORNA, HUMAN; MIRN149 MICRORNA, HUMAN; MIRN196 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN; TUMOR MARKER;

ARTICLE; CASE CONTROL STUDY; COLORECTAL TUMOR; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; META-ANALYSIS AS TOPIC; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894679759     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.1047     Document Type: Article

References (65)

1. Akkiz H, Bayram S, Bekar A, et al (2011). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev, 12, 3107-12.
2. Alshatwi AA, Shafi G, Hasan TN, et al (2012). Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One, 7, e30049.
3. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33.
4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
5. Bhaumik D, Scott GK, Schokrpur S, et al (2008). Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene, 27, 5643-7.
6. Brodersen P, Voinnet O (2009). Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Bio, 10, 141-8.
7. Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nature Reviews Cancer, 6, 857-66.
8. Catucci I, Yang R, Verderio P, et al (2010). Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat, 31, E1052-7.
9. Chae YS, Kim JG, Lee SJ, et al (2013). A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer Res, 33, 3233-9.
10. Chen H, Sun LY, Chen LL, et al (2012a). A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J, 42, e115-9.
11. Chen K, Song F, Calin GA, et al (2008). Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis, 29, 1306-11.
12. Chen P, Zhang J, Zhou F (2012b). miR-499 rs3746444 polymorphism is associated with cancer development among Asians and related to breast cancer susceptibility. Mol Biol Rep, 39, 10433-8.
13. Cheng T, Wang L, Li Y, et al (2013). Differential microRNA expression in renal cell carcinoma. Oncol Lett, 6, 769-76.
14. Cochran WG (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29.
15. Croce CM (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet, 10, 704-14.
16. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
17. Ding SL, Wang JX, Jiao JQ, et al (2013). A pre-microRNA-149 (miR-149) genetic variation affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis. J Biol Chem, 288, 26865-77.
18. Dominguez G (2013). Deciphering the epigenetic network in colorectal cancer. J Pathol, 229, 1-3.
19. Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
20. Fabian MR, Sonenberg N, Filipowicz W (2010). Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem, 79, 351-79.
21. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
22. Garcia A I, Cox DG, Barjhoux L, et al (2011). The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mutat, 32, 1004-7.
23. Garzon R, Calin GA, Croce CM (2009). MicroRNAs in cancer. Annu Rev Med, 60, 167-79.
24. Hezova R, Kovarikova A, Bienertova-Vasku J, et al (2012). Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol, 18, 2827-31.
25. Higgins J, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
26. Hoffman AE, Zheng T, Yi C, et al (2009). microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res, 69, 5970-7.
27. Hong MJ, Choi YY, Jang JA, et al (2013). Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC. J Thorac Oncol, 8, 703-10.
28. Hu X, Li L, Shang M, et al (2013). Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population. Tumour Biol.
29. Hu Z, Liang J, Wang Z, et al (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat, 30, 79-84.
30. Hurst DR, Edmonds MD, Scott GK, et al (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res, 69, 1279-83.
31. Jazdzewski K, Murray EL, Franssila K, et al (2008). Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A, 105, 7269-74.
32. Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610.
33. Landi D, Gemignani F, Barale R, Landi S (2008). A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. Dna Cell Biol, 27, 35-43.
34. Leung AK, Sharp PA (2010). MicroRNA functions in stress responses. Mol Cell, 40, 205-15.
35. Levin B, Lieberman DA, McFarland B, et al (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: a cancer journal for clinicians, 58, 130-60.
36. Li Y, Vandenboom T G, 2nd, Wang Z, et al (2010). miR-146a suppresses invasion of pancreatic cancer cells. Gastroenterology, 134, 1570-95.
37. Lin RJ, Lin YC, Yu AL (2010). miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog, 49, 719-27.
38. Lv M, Dong W, Li L, et al (2013). Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population. J Cancer Res Clin Oncol, 139, 1405-10.
39. Ma L, Zhu L, Gu D, et al (2013). A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population. Arch Toxicol, 87, 825-33.
40. Mantel N, Haenszel W (2004). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
41. Marino M, Cirello V, Gnarini V, et al (2013). Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer? Endocr Connect, 2, 178-85.
42. Meili L, Wei D, Yonggang W, et al (2013). Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese Population. J Cancer Res Clin Oncol, 139, 1405-10.
43. Min KT, Kim JW, Jeon YJ, et al (2012). Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog, 51, E65-73.
44. Mishra PJ, Bertino JR (2009). MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics, 10, 399-416.
45. Mueller DW, Bosserhoff AK (2011). MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer, 129, 1064-74.
46. Niinuma T, Suzuki H, Nojima M, et al (2012). Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res, 72, 1126-36.
47. Okubo M, Tahara T, Shibata T, et al (2010). Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter, 15, 524-31.
48. Schimanski CC, Frerichs K, Rahman F, et al (2009). High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol, 15, 2089.
49. Shi KQ, Lin Z, Li DW, et al (2013). Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer. Onkologie, 36, 560-5.
50. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
51. Tian T, Shu Y, Chen J, et al (2009). A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev, 18, 1183-7.
52. Tu HF, Liu CJ, Chang CL, et al (2012). The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. PLoS One, 7, e51606.
53. Vinci S, Gelmini S, Mancini I, et al (2013). Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods, 59, 138-46.
54. Visone R, Croce CM (2009). MiRNAs and cancer. Am J Pathol, 174, 1131-8.
55. Wang F, Sun GP, Zou YF, et al (2013). Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk. Mol Biol Rep, 40, 109-16.
56. Wang P, Xie S, Cui A, et al (2012). miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24, 697 subjects. Exp Ther Med, 3, 324-30.
57. Wei WJ, Wang YL, Li DS, et al (2013). Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis. PLoS One, 8, e56638.
58. Xiao C, Rajewsky K (2009). MicroRNA control in the immune system: basic principles. Cell, 136, 26-36.
59. Xu Y, Gu L, Pan Y, et al (2013b). Different effects of three polymorphisms in MicroRNAs on cancer risk in Asian population: evidence from published literatures. PLoS One, 8, e65123.
60. Xu Y, Li L, Xiang X, et al (2013a). Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene, 527, 584-93.
61. Zeng Y, Sun QM, Liu NN, et al (2010). Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol, 16, 3578-83.
62. Zhan JF, Chen LH, Chen ZX, et al (2011). A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res, 42, 144-8.
63. Zhang MW, Jin MJ, Yu YX, et al (2012). Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk. Mol Carcinog, 51, E21-31.
64. Zhou F, Zhu H, Luo D, et al (2012). A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. Dna Cell Biol, 31, 1290-5.
65. Zhu L, Chu H, Gu D, et al (2012). A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. Dna Cell Biol, 31, 350-4.